Genmab A/S (GMAB)

Genmab Stock Forecast

Stock Price Forecast

The 8 analysts that cover Genmab stock have a consensus rating of "Strong Buy" and an average price target of $39.81, which forecasts a 36.99% increase in the stock price over the next year. The lowest target is $32 and the highest is $48.

Price Target: $39.81 (+36.99%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$32	$39.81	$40	$48
Change	+10.12%	+36.99%	+37.65%	+65.18%

Analyst Ratings

The average analyst rating for Genmab stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	4	4	4	5	5	5
Buy	2	2	2	1	2	2
Hold	0	0	0	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	7	8	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Kalpit Patel Wolfe Research	Wolfe Research	Buy Initiates $32	Buy	Initiates	$32	+10.12%	Mar 27, 2026
Eva Fortea Verdejo Wells Fargo	Wells Fargo	Buy Initiates $40	Buy	Initiates	$40	+37.65%	Mar 2, 2026
Michael Schmidt Guggenheim	Guggenheim	Strong Buy Maintains $45 → $40	Strong Buy	Maintains	$45 → $40	+37.65%	Feb 23, 2026
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $39 → $40	Strong Buy	Maintains	$39 → $40	+37.65%	Feb 18, 2026
Benjamin Jackson Jefferies	Jefferies	Strong Buy Initiates $42	Strong Buy	Initiates	$42	+42.81%	Feb 17, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

4.39B

Increased by 18.09%

from 3.72B

Revenue Next Year

5.04B

Increased by 14.82%

from 4.39B

EPS This Year

12.31

Decreased by -19.89%

from 15.37

EPS Next Year

17.22

Increased by 39.83%

from 12.31

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Jan 1, 2024	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	1.29B	2.08B	2.39B	3.12B	3.72B	4.39B	5.04B
Revenue Growth	-22.52%	61.88%	14.68%	30.59%	19.19%	18.09%	14.82%
EPS	6.85	11.87	9.58	17.53	15.37	12.31	17.22
EPS Growth	-42.30%	73.29%	-19.27%	82.99%	-12.32%	-19.89%	39.83%
Forward PE	-	-	-	-	-	2.36	1.69
No. Analysts	-	-	-	-	-	23	23

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030
High	4.7B	5.6B
Avg	4.4B	5.0B
Low	3.6B	4.2B

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030
High	26.5%	27.3%
Avg	18.1%	14.8%
Low	-2.5%	-4.6%

EPS Forecast

EPS	2026	2027	2028	2029	2030
High	19.02	22.92
Avg	12.31	17.22
Low	10.28	9.79

EPS Growth

EPS Growth	2026	2027	2028	2029	2030
High	23.7%	86.2%
Avg	-19.9%	39.8%
Low	-33.1%	-20.5%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.